Pharmaceutical innovation, drug pricing, and patient access to essential medicines must work in a concerted fashion. Factors like: end up spiking the drug prices. Such
The drug products safety, quality and efficacy has repeatedly been the most talked-about topic in the pharmaceutical space. To be approved for marketing, it is
The Ministry of Commerce and Industry released the draft Patents (2nd Amendment) Rules, 2024 on 3rd January 2024. The draft rules focus on establishing a
Biosimilar medicine is a biologic product. The US Food and Drug Administration (FDA) and the European Medicines Agency (EMA) define a biosimilar product with certain
Patents provide intellectual property rights protection to newly invented products, services, and processes. The patentability criteria involve: To enforce these rights, patents must be registered
